HLA Health HourMedicaid & MedicareInsuranceMental HealthNutritionFind a ProviderHealth JobsProvider Corner
Healthcare Markets
UNH 340.01 ▼0.02%ELV 403.00 ▲1.93%CI 275.00 ▲1.29%CVS 80.97 ▲0.11%HUM 385.25 ▼1.25%CNC 63.94 ▲0.24%MOH 198.50 ▲0.00%HCA 475.00 ▼0.22%THC 263.00 ▼0.07%UHS 179.43 ▼0.12%LLY 1347.00 ▼0.13%PFE 27.40 ▼0.11%JNJ 270.93 ▲0.09%MRK 134.43 ▲0.48%ABBV 286.50 ▼0.35%NVO 37.84 ▲0.08%MDT 99.52 ▼0.55%ABT 104.33 ▲0.99%ISRG 400.17 ▲0.28%XLV 176.86 ▼0.28%Delayed quotes. Not investment advice.UNH 340.01 ▼0.02%ELV 403.00 ▲1.93%CI 275.00 ▲1.29%CVS 80.97 ▲0.11%HUM 385.25 ▼1.25%CNC 63.94 ▲0.24%MOH 198.50 ▲0.00%HCA 475.00 ▼0.22%THC 263.00 ▼0.07%UHS 179.43 ▼0.12%LLY 1347.00 ▼0.13%PFE 27.40 ▼0.11%JNJ 270.93 ▲0.09%MRK 134.43 ▲0.48%ABBV 286.50 ▼0.35%NVO 37.84 ▲0.08%MDT 99.52 ▼0.55%ABT 104.33 ▲0.99%ISRG 400.17 ▲0.28%XLV 176.86 ▼0.28%Delayed quotes. Not investment advice.
Saturday, November 21, 2026
Edition
HELPMORNING BRIEFING
HLA Network News
HealthLink of America
HEALTHLINK OF AMERICA NEWS / RESOURCES
NORTH CAROLINA HEALTH PLANS
NC MedicaidMedicareBlue Cross NCHealthy BlueAmeriHealth Caritas NCCarolina Complete HealthUnitedHealthcare Community PlanWellCare of NCAlliance HealthTrillium Health ResourcesVaya PartnersAetnaHumanaCigna
All plans ›
ADVERTISEMENT
ADVERTISE WITH HLA NETWORK NEWS
Reach patients, families and providers in their city.
Health brands only. Banner, sidebar, section, directory, jobs and Morning Briefing placements.
GET THE MEDIA KIT
Health Markets · national

Pancreatic cancer pill shows promise in early trial results

A daily pill called daraxonrasib combined with chemotherapy made tumors undetectable in some patients with advanced pancreatic cancer.

A daily pill called daraxonrasib appears to shrink and possibly eliminate tumors in some patients with advanced pancreatic cancer, according to BBC Health. In early medical trials, cancer became undetectable on scans in one in 12 patients who received daraxonrasib along with chemotherapy. Tumors stopped growing in almost all 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.

Experts are calling this the biggest breakthrough in pancreatic cancer treatment for decades, BBC Health reported. Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients. The charity noted that the drug has found a way to treat a disease that was previously considered very difficult to drug.

Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK, according to BBC Health. Although chemotherapy can shrink tumors somewhat, the cancer often grows again. Most patients with advanced disease survive months, not years.

Doctors stress that it is unclear how long the drug might keep the disease at bay and should not be seen as a cure, BBC Health reported. The trial followed patients for an average of a year and a half. Doctors hope the new treatment might offer patients more time, even if it cannot stop cancers permanently.

What it means in Raleigh

RALEIGH HEALTH SYSTEM
State agency: NC Department of Health and Human Services (NCDHHS)
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.

Sources

Not medical advice. HLA Network News reports health news. Talk to your doctor or care team about your own care. In a crisis, call or text 988. In an emergency, call 911.
ADVERTISEMENT · SIDEBAR 300x250
Reach health readers here. Advertise with HLA